Application of Quantitative Pharmacology in Development of Therapeutic Monoclonal Antibodies

Journal Title: The AAPS Journal - Year 2010, Vol 12, Issue 4

Abstract

The advancement of therapeutic monoclonal antibodies during various stages of the drug development process can be effectively streamlined when appropriate translational strategies are applied. Design of successful translational strategies for development of monoclonal antibodies should allow for understanding of the dose– and concentration–response relationships with respect to both beneficial and toxic effects from early phases of drug development. Evaluation of relevant biomarkers during early stages of drug development should facilitate the successful design of safe and effective dosing strategies. Moreover, application of quantitative pharmacology is critical for translation of exposure–response relationships early on.

Authors and Affiliations

Mohammad Tabrizi, Cherryl Funelas, Hamza Suria

Keywords

Related Articles

Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (II): In vitro evaluation of efficacy and toxicity

Patients undergoing anticoagulation with heparin or low molecular weight heparin (LMWH) require a superior antidote that possesses more selective biological actions and a better safety profile than protamine. We had prev...

Introduction to the Proposals from the Global Bioanalysis Consortium Harmonization Team

At the initiative of four regional professional organizations from Europe (European Bioanalysis Forum (EBF)) and North America (AAPS, Applied Pharmaceutical Analysis (APA) APA and Calibration & validation group (...

The Gender of Cell Lines Matters When Screening for Novel Anti-Cancer Drugs

Current reports indicated that the gender origin of cells is important in all facets of experimental biology. To explore this matter using an anticancer high throughput screening platform, seven male- and seven female-de...

A Priori Prediction of Tumor Payload Concentrations: Preclinical Case Study with an Auristatin-Based Anti-5T4 Antibody-Drug Conjugate

The online version of this article (doi:10.1208/s12248-014-9576-9) contains supplementary material, which is available to authorized users.

Chitosan and sodium alginate—Based bioadhesive vaginal tablets

Metronidazole was formulated in mucoadhesive vaginal tablets by directly compressing the natural cationic polymer chitosan, loosely cross-linked with glutaraldehyde, together with sodium alginate with or ine cellulose (M...

Download PDF file
  • EP ID EP681408
  • DOI  10.1208/s12248-010-9220-2
  • Views 88
  • Downloads 0

How To Cite

Mohammad Tabrizi, Cherryl Funelas, Hamza Suria (2010). Application of Quantitative Pharmacology in Development of Therapeutic Monoclonal Antibodies. The AAPS Journal, 12(4), -. https://europub.co.uk/articles/-A-681408